143 related articles for article (PubMed ID: 11140724)
1. Allosteric inhibition of fructose-1,6-bisphosphatase by anilinoquinazolines.
Wright SW; Hageman DL; McClure LD; Carlo AA; Treadway JL; Mathiowetz AM; Withka JM; Bauer PH
Bioorg Med Chem Lett; 2001 Jan; 11(1):17-21. PubMed ID: 11140724
[TBL] [Abstract][Full Text] [Related]
2. Anilinoquinazoline inhibitors of fructose 1,6-bisphosphatase bind at a novel allosteric site: synthesis, in vitro characterization, and X-ray crystallography.
Wright SW; Carlo AA; Carty MD; Danley DE; Hageman DL; Karam GA; Levy CB; Mansour MN; Mathiowetz AM; McClure LD; Nestor NB; McPherson RK; Pandit J; Pustilnik LR; Schulte GK; Soeller WC; Treadway JL; Wang IK; Bauer PH
J Med Chem; 2002 Aug; 45(18):3865-77. PubMed ID: 12190310
[TBL] [Abstract][Full Text] [Related]
3. Discovery of novel indole derivatives as allosteric inhibitors of fructose-1,6-bisphosphatase.
Bie J; Liu S; Li Z; Mu Y; Xu B; Shen Z
Eur J Med Chem; 2015 Jan; 90():394-405. PubMed ID: 25461330
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis and biological evaluation of 7-nitro-1H-indole-2-carboxylic acid derivatives as allosteric inhibitors of fructose-1,6-bisphosphatase.
Bie J; Liu S; Zhou J; Xu B; Shen Z
Bioorg Med Chem; 2014 Mar; 22(6):1850-62. PubMed ID: 24530031
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and biological evaluation of substituted 6-alkynyl-4-anilinoquinazoline derivatives as potent EGFR inhibitors.
Liu LT; Yuan TT; Liu HH; Chen SF; Wu YT
Bioorg Med Chem Lett; 2007 Nov; 17(22):6373-7. PubMed ID: 17889528
[TBL] [Abstract][Full Text] [Related]
6. Orally active aminopyridines as inhibitors of tetrameric fructose-1,6-bisphosphatase.
Hebeisen P; Haap W; Kuhn B; Mohr P; Wessel HP; Zutter U; Kirchner S; Ruf A; Benz J; Joseph C; Alvarez-Sánchez R; Gubler M; Schott B; Benardeau A; Tozzo E; Kitas E
Bioorg Med Chem Lett; 2011 Jun; 21(11):3237-42. PubMed ID: 21550236
[TBL] [Abstract][Full Text] [Related]
7. 3-(2-carboxyethyl)-4,6-dichloro-1H-indole-2-carboxylic acid: an allosteric inhibitor of fructose-1,6-bisphosphatase at the AMP site.
Wright SW; Carlo AA; Danley DE; Hageman DL; Karam GA; Mansour MN; McClure LD; Pandit J; Schulte GK; Treadway JL; Wang IK; Bauer PH
Bioorg Med Chem Lett; 2003 Jun; 13(12):2055-8. PubMed ID: 12781194
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis, and biological evaluation of substituted 2,3-dihydro-1H-cyclopenta[b]quinolin-9-ylamine related compounds as fructose-1,6-bisphosphatase inhibitors.
Rosini M; Mancini F; Tarozzi A; Colizzi F; Andrisano V; Bolognesi ML; Hrelia P; Melchiorre C
Bioorg Med Chem; 2006 Dec; 14(23):7846-53. PubMed ID: 16908175
[TBL] [Abstract][Full Text] [Related]
9. Design of EGFR kinase inhibitors: a ligand-based approach and its confirmation with structure-based studies.
Vema A; Panigrahi SK; Rambabu G; Gopalakrishnan B; Sarma JA; Desiraju GR
Bioorg Med Chem; 2003 Oct; 11(21):4643-53. PubMed ID: 14527561
[TBL] [Abstract][Full Text] [Related]
10. A library of novel allosteric inhibitors against fructose 1,6-bisphosphatase.
Heng S; Gryncel KR; Kantrowitz ER
Bioorg Med Chem; 2009 Jun; 17(11):3916-22. PubMed ID: 19419876
[TBL] [Abstract][Full Text] [Related]
11. Structure-guided design of AMP mimics that inhibit fructose-1,6-bisphosphatase with high affinity and specificity.
Erion MD; Dang Q; Reddy MR; Kasibhatla SR; Huang J; Lipscomb WN; van Poelje PD
J Am Chem Soc; 2007 Dec; 129(50):15480-90. PubMed ID: 18041833
[TBL] [Abstract][Full Text] [Related]
12. Benzoxazole benzenesulfonamides as allosteric inhibitors of fructose-1,6-bisphosphatase.
Lai C; Gum RJ; Daly M; Fry EH; Hutchins C; Abad-Zapatero C; von Geldern TW
Bioorg Med Chem Lett; 2006 Apr; 16(7):1807-10. PubMed ID: 16446092
[TBL] [Abstract][Full Text] [Related]
13. Benzoxazole benzenesulfonamides are novel allosteric inhibitors of fructose-1,6-bisphosphatase with a distinct binding mode.
von Geldern TW; Lai C; Gum RJ; Daly M; Sun C; Fry EH; Abad-Zapatero C
Bioorg Med Chem Lett; 2006 Apr; 16(7):1811-5. PubMed ID: 16442285
[TBL] [Abstract][Full Text] [Related]
14. Discovery of novel allosteric site and covalent inhibitors of FBPase with potent hypoglycemic effects.
Huang Y; Wei L; Han X; Chen H; Ren Y; Xu Y; Song R; Rao L; Su C; Peng C; Feng L; Wan J
Eur J Med Chem; 2019 Dec; 184():111749. PubMed ID: 31589992
[TBL] [Abstract][Full Text] [Related]
15. In silico screening of a novel scaffold for fructose-1,6-bisphosatase (FBPase) inhibitors.
Huang Y; Chi B; Xu Y; Song R; Wei L; Rao L; Feng L; Ren Y; Wan J
J Mol Graph Model; 2019 Jan; 86():142-148. PubMed ID: 30366190
[TBL] [Abstract][Full Text] [Related]
16. [Recent advance in the discovery of allosteric inhibitors binding to the AMP site of fructose-1,6-bisphosphatase].
Li ZM; Bie JB; Song HR; Xu BL
Yao Xue Xue Bao; 2011 Nov; 46(11):1291-300. PubMed ID: 22260018
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and evaluation of novel hybrids between 4-anilinoquinazolines and substituted triazoles as potent cytotoxic agents.
Le-Nhat-Thuy G; Dinh TV; Pham-The H; Nguyen Quang H; Nguyen Thi N; Dang Thi TA; Hoang Thi P; Le Thi TA; Nguyen HT; Nguyen Thanh P; Le Duc T; Nguyen TV
Bioorg Med Chem Lett; 2018 Dec; 28(23-24):3741-3747. PubMed ID: 30337229
[TBL] [Abstract][Full Text] [Related]
18. Anti-tubercular activity of novel 4-anilinoquinolines and 4-anilinoquinazolines.
Asquith CRM; Fleck N; Torrice CD; Crona DJ; Grundner C; Zuercher WJ
Bioorg Med Chem Lett; 2019 Sep; 29(18):2695-2699. PubMed ID: 31378571
[TBL] [Abstract][Full Text] [Related]
19. Inhibitors of src tyrosine kinase: the preparation and structure-activity relationship of 4-anilino-3-cyanoquinolines and 4-anilinoquinazolines.
Wang YD; Miller K; Boschelli DH; Ye F; Wu B; Floyd MB; Powell DW; Wissner A; Weber JM; Boschelli F
Bioorg Med Chem Lett; 2000 Nov; 10(21):2477-80. PubMed ID: 11078204
[TBL] [Abstract][Full Text] [Related]
20. Fructose-1,6-bisphosphatase Inhibitors. 2. Design, synthesis, and structure-activity relationship of a series of phosphonic acid containing benzimidazoles that function as 5'-adenosinemonophosphate (AMP) mimics.
Dang Q; Kasibhatla SR; Xiao W; Liu Y; Dare J; Taplin F; Reddy KR; Scarlato GR; Gibson T; van Poelje PD; Potter SC; Erion MD
J Med Chem; 2010 Jan; 53(1):441-51. PubMed ID: 20055427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
